by Biocross | Sep 7, 2017 | News
Tras un intenso curso en el campo de la salud en torno a la enfermedad de Alzheimer, estamos a punto de experimentar una nueva era en el trato de las enfermedades neurodegenerativas. Por un lado, se están produciendo avances en el terreno legislativo para asegurar la...
by Biocross | Jul 25, 2017 | News
Entrevista a Matt Mittino Hoy por Hoy Valladolid – Cadena Ser 25 de julio de 2017
by Biocross | Jul 25, 2017 | News
La empresa vallisoletana Biocross es una spin off —una empresa que nace como extensión de otra mediante la separación de una división subsidiaria— del CSIC (Consejo Superior de Investigaciones Científicas). ¿Su objetivo? Estudiar nuevos biomarcadores para el...
by Biocross | Jul 24, 2017 | News
By Labmedica International staff writers Posted on 24 Jul 2017 A clinical diagnostic kit that measures the concentration of the Alzheimer’s disease blood biomarker APOEepsilon4 was unveiled at the Alzheimer’s Association Conference held in London, United...
by Biocross | Sep 21, 2016 | News
The diagnosis of Alzheimer’s disease is established through a series of neuropsychological tests, images obtained by MRI or CT scan, and the analysis of markers obtained by lumbar puncture. “Diagnosis is reached by putting together all this...
by Biocross | Mar 26, 2015 | News
Early diagnosis of this disease is one of the factors that would enable better treatment. This is a key focus of many of the biotechnology companies that have emerged in recent decades. In Spain and in other countries, several research projects are currently underway,...
